MACSEN DRUGS

Overview

MACSEN DRUGS is an active pharmaceutical ingredient (API) supplier with 10 active FDA Type II Drug Master Files, covering FLUORESCEIN SODIUM USP; INDIGOTINDISULFONATE SODIUM USP; INDOCYANINE GREEN USP; METHYLENE BLUE USP; SELENIOUS ACID USP; SELENIUM SULFIDE USP.

API / Drug Master Files

MACSEN DRUGS holds 10 active (10 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• SILVER NITRATE USPActive2025-09-26
• SODIUM SELENITE PH. EUR./BPActive2025-09-26
• SODIUM SELENITE PENTAHYDRATE PH. EUR./BPActive2025-09-26
• INDOCYANINE GREEN USPActive2024-06-27
• INDIGOTINDISULFONATE SODIUM USPActive2024-06-25
• SELENIOUS ACID USPActive2023-12-27
• FLUORESCEIN SODIUM USPActive2023-09-27
• SELENIUM SULFIDE USPActive2023-02-21
• METHYLENE BLUE USPActive2020-08-17
• SILVER SULFADIAZINE USPActive2018-08-08

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to MACSEN DRUGS in our records. PharmaTek screens the full directory against live FDA enforcement data.